Risk Factors for Severe Hypertension and Proteinuria After Treatment With Vascular Endothelial Growth Factor Signaling Pathway Inhibitors Among Patients With Cancer

Authors

• Paul E Hanna
• Rajesh K Anumolu
• Shveta S Motwani
• Kevin L Chen
• Nurit Katz-Agranov
• Olivia Green-Lingren
• Osman A Yilmam
• Kenar D Jhaveri
• Abhijat Kitchlu
• Jaya Kala
• Meghan E Sise
• Shruti Gupta

Language

English

Publication Date

6-1-2024

Journal

Kidney International Reports

DOI

10.1016/j.ekir.2024.03.005

PMID

38899179

PMCID

PMC11184235

PubMedCentral® Posted Date

5-13-2024

PubMedCentral® Full Text Version

Post-print

Published Open-Access

yes

Recommended Citation

Hanna, Paul E; Anumolu, Rajesh K; Motwani, Shveta S; et al., "Risk Factors for Severe Hypertension and Proteinuria After Treatment With Vascular Endothelial Growth Factor Signaling Pathway Inhibitors Among Patients With Cancer" (2024). Faculty, Staff and Student Publications. 3634.
https://digitalcommons.library.tmc.edu/uthmed_docs/3634